Cedar Mountain Advisors
KURA icon

Cedar Mountain Advisors’s Kura Oncology KURA Stock Holding History

Cedar Mountain Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.8K Hold
542
– – ﹤0.01% 609
2026
Q2 		$5.95K Hold
542
– – ﹤0.01% 640
2026
Q1 		$4.41K Buy
+542
New +$4.66K ﹤0.01% 694

Other funds holding KURA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Flower City Capital
Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Sanders Morris Harris
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Cedar Mountain Advisors's KURA Position: Q3 2026 in Review

Cedar Mountain Advisors held its Kura Oncology (KURA) position steady in Q3 2026 at 542 shares worth $5.8K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Cedar Mountain Advisors first reported a position in KURA in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.95K in Q2 2026. 23 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Cedar Mountain Advisors held 542 shares of Kura Oncology worth $5.8K as of Q3 2026.
  • Cedar Mountain Advisors left its Kura Oncology share count unchanged in Q3 2026.
  • Kura Oncology made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #609 holding.
  • Cedar Mountain Advisors first reported a position in Kura Oncology in Q1 2026 and has held it in 3 quarters since.
  • Cedar Mountain Advisors's Kura Oncology position peaked at $5.95K in Q2 2026.
  • 23 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.